<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen X</submitter><funding>Discipline Promotion Project of Xijing Hospital</funding><funding>the National Natural Science Foundation of China</funding><pagination>195</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7388495</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Hyperbilirubinemia is one of the common complications after cardiac surgery and is associated with increased mortality. However, to the best of our knowledge, the reports on clinical significance of postoperative severe hyperbilirubinemia in Stanford type A aortic dissection (AAD) patients were limited.&lt;h4>Methods&lt;/h4>Patients who underwent surgical treatment for AAD in our center between January 2015 and December 2018 were retrospectively screened. In-hospital mortality, long-term mortality, acute kidney injury (AKI), and the requirement of continuous renal replacement therapy (CRRT) were assessed as endpoints. Univariate and multivariate regression models were employed to identify the risk factors of these endpoints.&lt;h4>Results&lt;/h4>After screening, 271 patients were in</pubmed_abstract><journal>Journal of cardiothoracic surgery</journal><pubmed_title>Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study.</pubmed_title><pmcid>PMC7388495</pmcid><funding_grant_id>XJZT18ML16</funding_grant_id><funding_grant_id>81700584</funding_grant_id><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Sun S</pubmed_authors><pubmed_authors>Bai M</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Ma F</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Hyperbilirubinemia is one of the common complications after cardiac surgery and is associated with increased mortality. However, to the best of our knowledge, the reports on clinical significance of postoperative severe hyperbilirubinemia in Stanford type A aortic dissection (AAD) patients were limited.&lt;h4>Methods&lt;/h4>Patients who underwent surgical treatment for AAD in our center between January 2015 and December 2018 were retrospectively screened. In-hospital mortality, long-term mortality, acute kidney injury (AKI), and the requirement of continuous renal replacement therapy (CRRT) were assessed as endpoints. Univariate and multivariate regression models were employed to identify the risk factors of these endpoints.&lt;h4>Results&lt;/h4>After screening, 271 patients were in</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-05T15:20:56.039Z</modification><creation>2020-11-19T08:19:33Z</creation></dates><accession>S-EPMC7388495</accession><cross_references><pubmed>32723390</pubmed><doi>10.1186/s13019-020-01243-7</doi></cross_references></HashMap>